Skip to main content

SPECT or SPECT/CT: what the CT adds, what it really costs, and when standalone is the right buy

By Vvon Engineering Team | Published | Updated

Compare the clinical role of hybrid CT with its site, staffing, quality-control, maintenance and exposure requirements when specifying a SPECT service.

Nuclear medicine RFQ checklist (TXT)

Compare SPECT/CT with standalone SPECT using the full clinical and ownership scope: CT functions, site requirements, qualified staff, QA, maintenance and authorisation. CT tube replacement is a financial risk to model, not an event with one guaranteed service interval.

None of which argues against buying one. Hybrid imaging changes reports in ways that change management, and for some case mixes it is straightforwardly the correct decision. The point is to decide against the whole cost and your own case mix rather than against a demonstration image.

Attenuation correction and its clinical role

Photons emitted deep in the body are attenuated more than superficial ones, so an uncorrected SPECT systematically under-represents deep structures. In the chest this produces predictable false defects: breast tissue over the anterior wall, the diaphragm and sub-diaphragmatic activity under the inferior wall, and a general loss of confidence in large patients.

CT can provide an attenuation map and anatomical information for an appropriately registered reconstruction. Quantitative SPECT requires a validated chain of calibration and corrections; CT-based attenuation correction is common but is not the only possible attenuation method. Neither CT alone nor an activity calibration alone establishes quantitative accuracy.

Correction methods must be validated for the system and protocol. Attenuation correction does not universally require resolution recovery to be beneficial. Misregistration, scatter modelling and other errors can create artefacts; review the appropriate corrected, uncorrected and fused data under the clinical and physics procedure.

Localisation is what actually changes reports

Anatomical localisation can improve interpretation in selected indications, alongside the functional information. Its value depends on the clinical question; an actionable SPECT or planar result does not always require hybrid CT.

Clinical areaPotential role of CTDecision to assess
Bone, parathyroid and other focal findingsAnatomical localisation where planar/SPECT findings need contextWhether additional CT changes interpretation or management
Infection and selected oncology studiesLocalisation and correlation with structural findingsIndication, tracer and access to existing imaging
Myocardial perfusionAttenuation correction in a validated workflowCorrection method, registration and clinical quality
Renal, thyroid and other functional studiesAnatomical information for selected questionsWhether CT is justified rather than routinely added
Quantitative SPECTAttenuation information as part of a validated correction chainCalibration, scatter and other corrections, uncertainty and clinical purpose

Review the clinical questions and how often CT information is expected to change interpretation or management. The fraction of a few named studies alone cannot determine whether attenuation maps are useful.

What the CT costs beyond the invoice

The artefacts the CT brings with it

All of these argue for the same working rule: keep the uncorrected reconstruction and read both. A department that reads only the corrected series will eventually report a misregistration artefact as a lesion, and will have no way of knowing it did.

A decision rule, stated honestly

Choose the modality using clinically justified studies, required quantification, access to other imaging and the complete support plan. SPECT/CT can add value for several listed indications, but a generic case-mix rule cannot replace clinical appraisal. Confirm whether and how the SPECT subsystem can operate during a CT fault; failure of one does not always disable both.

If waiting time is the concern, identify whether acquisition, preparation, staffing or reporting is the bottleneck before comparing an additional camera with hybrid capability.

If you buy standalone, buy it properly

For standalone SPECT, specify supported reconstruction and corrections, compatible collimators, QA and archiving for the intended studies. Confirm the real upgrade path and any manufacturer-approved external positioning aids. Future collimator cost and delivery, warranty evidence and power requirements must be agreed rather than assumed.

Both routes are legitimate. The mistake is treating the hybrid as the default because it is the newer product, and then running it with a CT nobody is permitted to report, an attenuation correction nobody validates, and a tube replacement nobody budgeted for. A well specified standalone camera with the right collimators, a working QA programme and a stable power supply will serve a Bangladeshi department better than a hybrid system that is out of service waiting for a part.

Vvon's catalogue includes MiE gamma-camera/SPECT configurations and Spectrum Dynamics SPECT products; D-SPECT cardiac systems should not be described as integrated SPECT/CT merely because they appear alongside VERITON-CT. Confirm the exact hardware and options. Anti-scatter grids inside CT equipment are manufacturer-specific components, not a generic hospital retrofit. Contact +8801805987890 or info@vvon.com.bd with the proposed study mix.

Technical references

Have a project to scope?

Share your application, equipment requirements and procurement timeline. Our engineers can help clarify the configuration and scope for your enquiry.

Discuss your requirements

Browse buying and selection guides | Back to all Insights